K-numberK243789
Device nameLIBERTY Endovascular Robotic System (LIBERTYOS)
ApplicantMicrobot Medical , Ltd.
Product codeDXX
Device classClass II
Decision dateSep 4, 2025
DecisionSubstantially Equivalent
Regulation870.1290
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The LIBERTY Endovascular Robotic System is a single-use, sterile, disposable device that enables physicians to remotely deliver and manipulate guidewires, catheters, and guide catheters to navigate to targets in the peripheral vasculature. The physician controls the system wirelessly from a handheld remote controller while seated away from X-ray radiation, reducing radiation exposure during peripheral endovascular procedures.

Technological characteristics

The LIBERTY system features a motorized bedside robotic drive, a wireless handheld remote controller (Bluetooth), and a mechanical articulated mounting arm. Compared to the Magellan predicate, LIBERTY has a more compact, portable, single-use design with wireless control instead of a wired console. Both systems use master-slave servo motor/encoder control to enable independent linear and rotational movement of guidewires and catheters.

Test standards cited

Not stated in this summary. The document references V&V testing but does not cite specific ISO, IEC, ASTM, or other consensus standards.

Substantial equivalence argument

LIBERTY is substantially equivalent to the Magellan predicate because both devices share the same regulatory class (Class II), product code (DXX), and core operational principle: remote manipulation of guidewires and catheters using motorized servo control in peripheral vascular interventions. Although LIBERTY differs in design (compact, single-use, wireless), these differences do not raise new safety or effectiveness questions because performance testing—including human factors validation, GLP-certified animal studies, and a clinical study showing 100% success rate with no serious adverse events—demonstrates equivalent safety and effectiveness profiles.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →